Accessibility Menu
Isodiol International logo

Isodiol International(OTC) ISOLF

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Isodiol International last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-30
Isodiol International stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-10
1 month+0%USD 0.002026-06-26
3 month+0%USD 0.002026-03-26
Year to date+0%USD 0.002025-12-26
1 year+0%USD 0.002025-07-25
3 year+0%USD 0.002023-07-28
5 year-100%USD 0.042021-07-30
Since inception-100%USD 0.942017-05-19

Isodiol International Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$11.92K

Net Income (TTM)

-$73.39K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-17.32 (Low)

Price

$0.00

Volume

1,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Nov 27, 2024

ISOLF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Isodiol International

Isodiol International Inc. is a company focused on developing, marketing, and distributing consumer products derived from hemp. The company operates in both Canada and the United States, specializing in high-purity cannabinoid isolates and advanced delivery systems for various consumer applications.

Products and Services
  • Pharmaceutical-grade crystalline cannabinoid isolates
  • Hemp-infused beverages and skincare products
  • Manufacturing and distribution of hemp oil and nicotine e-liquids
Growth Outlook
  • Expanding product line to meet increasing consumer demand
  • Utilizing advanced technologies like nanotechnology for product enhancement
  • Strategic partnerships to enhance market reach and distribution
Financial Highlights
  • Recent quarterly revenue of $1,020, indicating potential for growth
  • Trailing twelve months (TTM) revenue of $6,262, showcasing historical performance
  • Current ratio of 1.73, indicating strong short-term financial health
Isodiol International Inc. is positioned in the rapidly growing hemp-derived product market, leveraging its expertise in cannabinoid extraction and product development. The company's focus on high-quality, pharmaceutical-grade products aligns with increasing consumer interest in natural health solutions. Recent financial data indicates a revenue trajectory that, while modest, reflects the potential for future growth as the market expands. The strategic use of advanced technologies and partnerships further enhances the company's prospects, making it a noteworthy consideration for investors interested in the evolving hemp industry.
AI Generated • Jul 26, 2026

Industry

Pharmaceuticals

Headquarters

Vancouver, BC V6C 1S4, CA

ISOLF Financials

Key Financial Metrics (TTM)

Gross Margin

-24.35%

Operating Margin

-175.52%

Net Income Margin

-542.13%

Return on Equity

-427.45%

Return on Capital

-259.83%

Return on Assets

-510.68%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

1.00K

Avg. Volume

111.111

Financials (TTM)

Gross Profit

$2.26K

Operating Income

-$22.05K

EBITDA

-$91.30M

Operating Cash Flow

$6.44K

Capital Expenditure

$4.02K

Free Cash Flow

$10.47K

Cash & ST Invst.

$1.16K

Total Debt

$4.37K

Isodiol International Performance Analysis

Isodiol International sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42019-03-31-7.8%
Q12019-06-30-48.6%
Q22019-09-30-56.0%
Q32019-12-31-28.0%
Isodiol International sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42019-03-31-18727.5%
Q12019-06-3099.9%
Q22019-09-30-13.4%
Q32019-12-3169.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2019YOY CHG

Revenue

$1.02K

-85.0%

Gross Profit

$377.00

-87.5%

Gross Margin

36.96%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

-$747.04

+95.3%

EBITDA

-$622.18K

+95.0%

Quarterly Fundamentals

Name
Q3 2019YOY CHG

Total Cash

$1.16K

-36.7%

Total Debt

$4.37K

-27.7%

Accounts Receivable

$1.68M

-57.4%

Inventory

$1.97K

-60.7%

Long Term Debt

$5.68M

+146247.9%

Short Term Debt

$169.81K

+7737.4%

Return on Assets

-5.11%

N/A

Return on Invested Capital

-3.22%

N/A

Free Cash Flow

$180.32

+102.3%

Operating Cash Flow

$180.32

+102.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OWCPOWC Pharmaceutical Research Corp.
$0.00+0.00%
NUNZNunzia Pharmaceutical Company
$0.00+0.00%
HENCHero Technologies Inc.
$0.00+0.00%
CBGLCannabis Global Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About ISOLF

What is the current price of Isodiol International?

Isodiol International is trading at $0.00 per share.

What is the 52-week range for Isodiol International?

Over the past 52 weeks, Isodiol International has traded between $0.00 and $0.00.

How much debt does Isodiol International have?

Isodiol International total debt is unavailable.

How much cash does Isodiol International have on hand?

Isodiol International does not have cash on hand data available.

What is Isodiol International’s dividend yield?

Isodiol International does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.